ROXRO PHARMA, Inc. develops drugs for pain treatment. Its products include ROX-888, an intranasal formulation for the treatment of dental and postoperative pain; and ROX-828, a non-opioid and non-triptan intranasal product for the treatment of migraine. ROXRO PHARMA, Inc. was founded in 1999 and is based in Menlo Park, California.

Overview

Total FundingEmployeesLast Funding DateStatus
$68,800,0001-102007-06-12Closed

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2001-07-20$4,500,000Venture
2007-06-12$42,700,000VentureSutter Hill Ventures, Prospect Venture PartnersThomas Weisel Partners
2005-10-19$21,600,000VentureSutter Hill Ventures, Prospect Venture Partners